ANZUPGO DIN 02560704
Health Canada record
| Active ingredient(s) | DELGOCITINIB 20 MG |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D11AH11 DELGOCITINIB |
| Original market date | 28-Aug-2025 |
| Current status date | 28-Aug-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
LEO Pharma Inc — licence 100195, currently licensed, last inspection rating C (2026-05-27).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35893 | 2025-08-25 | New Drug Submission (NDS) |